Symbols / MDWD
MDWD Chart
About
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 225.90M |
| Enterprise Value | 174.45M | Income | -20.60M | Sales | 20.93M |
| Book/sh | 3.91 | Cash/sh | 4.61 | Dividend Yield | — |
| Payout | 0.00% | Employees | 111 | IPO | — |
| P/E | — | Forward P/E | -7.07 | PEG | — |
| P/S | 10.79 | P/B | 4.50 | P/C | — |
| EV/EBITDA | -7.70 | EV/Sales | 8.33 | Quick Ratio | 2.48 |
| Current Ratio | 2.65 | Debt/Eq | 16.49 | LT Debt/Eq | — |
| EPS (ttm) | -1.84 | EPS next Y | -2.49 | EPS Growth | — |
| Revenue Growth | 24.70% | Earnings | 2026-03-05 | ROA | -17.41% |
| ROE | -48.83% | ROIC | — | Gross Margin | 18.53% |
| Oper. Margin | -120.19% | Profit Margin | -98.43% | Shs Outstand | 12.84M |
| Shs Float | 9.75M | Short Float | 11.43% | Short Ratio | 9.79 |
| Short Interest | — | 52W High | 22.50 | 52W Low | 14.14 |
| Beta | 0.13 | Avg Volume | 99.52K | Volume | 29.55K |
| Target Price | $31.50 | Recom | None | Prev Close | $17.57 |
| Price | $17.60 | Change | 0.17% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$31.50
Mean price target
2. Current target
$17.60
Latest analyst target
3. DCF / Fair value
$-21.31
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$17.60
Low
$25.00
High
$39.00
Mean
$31.50
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-11-21 | main | HC Wainwright & Co. | Buy → Buy | $36 |
| 2025-05-22 | main | HC Wainwright & Co. | Buy → Buy | $31 |
| 2025-03-20 | reit | HC Wainwright & Co. | Buy → Buy | $25 |
| 2025-02-28 | init | Craig-Hallum | — → Buy | $39 |
| 2025-01-10 | reit | HC Wainwright & Co. | Buy → Buy | $25 |
| 2024-11-27 | main | HC Wainwright & Co. | Buy → Buy | $25 |
| 2024-10-11 | reit | HC Wainwright & Co. | Buy → Buy | $28 |
| 2024-08-15 | reit | HC Wainwright & Co. | Buy → Buy | $28 |
| 2024-07-16 | reit | HC Wainwright & Co. | Buy → Buy | $28 |
| 2024-05-30 | reit | HC Wainwright & Co. | Buy → Buy | $28 |
| 2024-03-22 | reit | HC Wainwright & Co. | Buy → Buy | $28 |
| 2024-01-16 | main | HC Wainwright & Co. | Buy → Buy | $28 |
| 2023-11-22 | reit | HC Wainwright & Co. | Buy → Buy | $26 |
| 2023-09-21 | main | HC Wainwright & Co. | Buy → Buy | $26 |
| 2023-08-17 | main | Oppenheimer | Outperform → Outperform | $36 |
| 2023-08-17 | reit | HC Wainwright & Co. | Buy → Buy | $23 |
| 2023-05-31 | reit | Oppenheimer | Outperform → Outperform | $63 |
| 2023-05-31 | reit | HC Wainwright & Co. | Buy → Buy | $23 |
| 2023-03-17 | reit | HC Wainwright & Co. | — → Buy | $23 |
| 2023-01-04 | main | HC Wainwright & Co. | — → Buy | $23 |
- MediWound Shareholders Approve Expansion of 2024 Equity Incentive Pool - The Globe and Mail Fri, 20 Feb 2026 08
- MediWound lines up talks at two health-care investor conferences - Stock Titan ue, 17 Feb 2026 13
- MediWound Is A Buy Opportunity On The Dip (NASDAQ:MDWD) - Seeking Alpha ue, 02 Sep 2025 07
- MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance hu, 20 Nov 2025 08
- How (MDWD) Movements Inform Risk Allocation Models - Stock Traders Daily Sun, 15 Feb 2026 01
- Getting In Cheap On MediWound Ltd. (NASDAQ:MDWD) Might Be Difficult - simplywall.st hu, 16 Oct 2025 07
- MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference - GlobeNewswire Mon, 12 Jan 2026 08
- MediWound Stock: Undervalued High-Growth Potential (NASDAQ:MDWD) - Seeking Alpha Fri, 16 May 2025 07
- MediWound (NASDAQ:MDWD) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance Sat, 22 Nov 2025 08
- The MediWound Ltd. (NASDAQ:MDWD) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st Sun, 23 Nov 2025 08
- Earnings To Watch: MediWound Ltd (MDWD) Reports Q1 2025 Result - GuruFocus ue, 20 May 2025 07
- (MDWD) and the Role of Price-Sensitive Allocations - Stock Traders Daily Mon, 12 Jan 2026 08
- MediWound Lays Out Growth Path With EscharEx Progress, NexoBrid Scale-Up and Strong Cash Position - TipRanks Mon, 12 Jan 2026 08
- MediWound Ltd. (NASDAQ:MDWD) is a favorite amongst institutional investors who own 52% - Yahoo Finance Fri, 19 Dec 2025 08
- MediWound (MDWD) Q2 2025 Earnings Call Transcript - The Globe and Mail hu, 14 Aug 2025 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -2.25M | 1.65M | -1.87M | -137.97K |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -17.20M | -12.67M | -9.33M | -10.87M |
| TotalUnusualItems | -10.73M | 7.87M | -8.92M | -511.00K |
| TotalUnusualItemsExcludingGoodwill | -10.73M | 7.87M | -8.92M | -511.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -30.22M | -6.72M | -19.60M | -13.55M |
| ReconciledDepreciation | 1.48M | 1.30M | 1.27M | 1.24M |
| ReconciledCostOfRevenue | 16.33M | 14.04M | 12.33M | 14.04M |
| EBITDA | -27.93M | -4.80M | -18.25M | -11.38M |
| EBIT | -29.41M | -6.10M | -19.52M | -12.62M |
| NetInterestIncome | -35.00K | 1.10M | -2.26M | -1.79M |
| InterestExpense | 752.00K | 427.00K | 0.00 | 903.00K |
| InterestIncome | 2.05M | 2.34M | 270.00K | 11.00K |
| NormalizedIncome | -21.75M | -12.93M | -12.55M | -13.18M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -30.22M | -6.72M | -19.60M | -13.55M |
| TotalExpenses | 39.60M | 34.19M | 34.16M | 34.98M |
| TotalOperatingIncomeAsReported | -19.40M | -15.29M | -8.35M | -11.22M |
| DilutedAverageShares | 9.96M | 9.01M | 4.99M | 3.89M |
| BasicAverageShares | 9.96M | 9.01M | 4.99M | 3.89M |
| DilutedEPS | -3.03 | -0.75 | -3.93 | -3.50 |
| BasicEPS | -3.03 | -0.75 | -3.93 | -3.50 |
| DilutedNIAvailtoComStockholders | -30.22M | -6.72M | -19.60M | -13.55M |
| NetIncomeCommonStockholders | -30.22M | -6.72M | -19.60M | -13.55M |
| NetIncome | -30.22M | -6.72M | -19.60M | -13.55M |
| NetIncomeIncludingNoncontrollingInterests | -30.22M | -6.72M | -19.60M | -13.55M |
| NetIncomeDiscontinuousOperations | 0.00 | 0.00 | ||
| NetIncomeContinuousOperations | -30.22M | -6.72M | -19.60M | -13.55M |
| TaxProvision | 61.00K | 185.00K | 78.00K | 27.00K |
| PretaxIncome | -30.16M | -6.53M | -19.52M | -13.52M |
| OtherIncomeExpense | -10.75M | 7.87M | -9.60M | -511.00K |
| OtherNonOperatingIncomeExpenses | -18.00K | -684.00K | -710.00K | |
| SpecialIncomeCharges | 211.00K | |||
| OtherSpecialCharges | -211.00K | |||
| GainOnSaleOfSecurity | -10.73M | 7.66M | -8.92M | -511.00K |
| NetNonOperatingInterestIncomeExpense | -35.00K | 1.10M | -2.26M | -1.79M |
| TotalOtherFinanceCost | 1.33M | 811.00K | 2.53M | 900.00K |
| InterestExpenseNonOperating | 752.00K | 427.00K | 0.00 | 903.00K |
| InterestIncomeNonOperating | 2.05M | 2.34M | 270.00K | 11.00K |
| OperatingIncome | -19.38M | -15.50M | -7.66M | -11.22M |
| OperatingExpense | 22.02M | 19.08M | 20.83M | 19.99M |
| OtherOperatingExpenses | 684.00K | |||
| DepreciationAmortizationDepletionIncomeStatement | 228.00K | 235.00K | 274.00K | 283.00K |
| DepreciationAndAmortizationInIncomeStatement | 228.00K | 235.00K | 274.00K | 283.00K |
| ResearchAndDevelopment | 8.88M | 7.47M | 10.18M | 10.26M |
| SellingGeneralAndAdministration | 12.91M | 11.38M | 10.37M | 9.45M |
| SellingAndMarketingExpense | 3.20M | 2.80M | 2.04M | 1.70M |
| GeneralAndAdministrativeExpense | 9.71M | 8.57M | 8.33M | 7.75M |
| OtherGandA | 3.15M | 3.06M | 3.35M | 3.20M |
| SalariesAndWages | 6.57M | 5.51M | 4.98M | 4.55M |
| GrossProfit | 2.63M | 3.58M | 13.16M | 8.77M |
| CostOfRevenue | 17.59M | 15.11M | 13.33M | 14.99M |
| TotalRevenue | 20.22M | 18.69M | 26.50M | 23.76M |
| OperatingRevenue | 20.22M | 18.69M | 26.50M | 23.76M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 10.79M | 9.22M | 7.24M | 3.90M |
| ShareIssued | 10.79M | 9.22M | 7.24M | 3.90M |
| TotalDebt | 6.51M | 6.35M | 846.00K | 1.39M |
| TangibleBookValue | 31.05M | 31.43M | 10.68M | -4.88M |
| InvestedCapital | 31.15M | 31.59M | 10.91M | -4.58M |
| WorkingCapital | 25.62M | 31.57M | 33.78M | 4.23M |
| NetTangibleAssets | 31.05M | 31.43M | 10.68M | -4.88M |
| CapitalLeaseObligations | 6.51M | 6.35M | 846.00K | 1.39M |
| CommonStockEquity | 31.15M | 31.59M | 10.91M | -4.58M |
| TotalCapitalization | 31.15M | 31.59M | 10.91M | -4.58M |
| TotalEquityGrossMinorityInterest | 31.15M | 31.59M | 10.91M | -4.58M |
| StockholdersEquity | 31.15M | 31.59M | 10.91M | -4.58M |
| GainsLossesNotAffectingRetainedEarnings | -11.00K | -18.00K | -5.00K | -19.00K |
| ForeignCurrencyTranslationAdjustments | -11.00K | -18.00K | -5.00K | -19.00K |
| RetainedEarnings | -205.05M | -174.82M | -168.11M | -148.51M |
| AdditionalPaidInCapital | 236.00M | 206.25M | 178.88M | 143.87M |
| CapitalStock | 215.00K | 184.00K | 143.00K | 75.00K |
| CommonStock | 215.00K | 184.00K | 143.00K | 75.00K |
| TotalLiabilitiesNetMinorityInterest | 42.34M | 34.86M | 39.10M | 24.33M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 15.80M | 16.74M | 27.05M | 13.61M |
| OtherNonCurrentLiabilities | 8.15M | 9.93M | 10.23M | 11.81M |
| DerivativeProductLiabilities | 7.30M | 15.61M | 0.00 | |
| EmployeeBenefits | 404.00K | 456.00K | 360.00K | 288.00K |
| NonCurrentPensionAndOtherPostretirementBenefitPlans | 404.00K | 456.00K | 360.00K | 288.00K |
| NonCurrentDeferredLiabilities | 736.00K | 0.00 | 0.00 | 119.00K |
| NonCurrentDeferredRevenue | 736.00K | 0.00 | 0.00 | 119.00K |
| LongTermDebtAndCapitalLeaseObligation | 6.51M | 6.35M | 846.00K | 1.39M |
| LongTermCapitalLeaseObligation | 6.51M | 6.35M | 846.00K | 1.39M |
| CurrentLiabilities | 26.54M | 18.12M | 12.06M | 10.72M |
| OtherCurrentLiabilities | 17.70M | 8.71M | 2.24M | 2.41M |
| CurrentDeferredLiabilities | 457.00K | 24.00K | 63.00K | 543.00K |
| CurrentDeferredRevenue | 457.00K | 24.00K | 63.00K | 543.00K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 417.00K | 417.00K | ||
| PayablesAndAccruedExpenses | 8.38M | 9.39M | 9.75M | 7.35M |
| CurrentAccruedExpenses | 3.97M | 3.41M | 2.47M | 1.64M |
| Payables | 4.41M | 5.98M | 7.28M | 5.71M |
| OtherPayable | 226.00K | 1.68M | 1.32M | 780.00K |
| DuetoRelatedPartiesCurrent | 86.00K | 83.00K | 307.00K | 241.00K |
| AccountsPayable | 4.10M | 4.22M | 5.66M | 4.69M |
| TotalAssets | 73.50M | 66.46M | 50.02M | 19.74M |
| TotalNonCurrentAssets | 21.33M | 16.76M | 4.18M | 4.79M |
| OtherNonCurrentAssets | 439.00K | 440.00K | 184.00K | |
| NonCurrentAccountsReceivable | 233.00K | 180.00K | 469.00K | |
| GoodwillAndOtherIntangibleAssets | 99.00K | 165.00K | 231.00K | 297.00K |
| OtherIntangibleAssets | 99.00K | 165.00K | 231.00K | 297.00K |
| NetPPE | 20.80M | 15.93M | 3.58M | 4.03M |
| AccumulatedDepreciation | -7.93M | -7.14M | -6.46M | -5.86M |
| GrossPPE | 28.73M | 23.06M | 10.04M | 9.88M |
| Leases | 3.45M | 3.38M | 3.28M | 3.14M |
| OtherProperties | 6.70M | 1.22M | 1.55M | |
| MachineryFurnitureEquipment | 18.15M | 12.99M | 5.55M | 5.20M |
| BuildingsAndImprovements | 7.12M | |||
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 52.16M | 49.70M | 45.84M | 14.95M |
| RestrictedCash | 34.01M | 29.84M | 0.00 | 0.00 |
| PrepaidAssets | 458.00K | 722.00K | 287.00K | 439.00K |
| Inventory | 2.69M | 2.85M | 1.96M | 1.20M |
| FinishedGoods | 1.25M | 1.85M | 1.05M | 506.00K |
| RawMaterials | 1.44M | 995.00K | 913.00K | 694.00K |
| Receivables | 5.85M | 4.42M | 9.70M | 2.27M |
| OtherReceivables | 1.05M | 719.00K | 363.00K | 488.00K |
| AccountsReceivable | 4.80M | 3.70M | 9.33M | 1.78M |
| AllowanceForDoubtfulAccountsReceivable | -117.00K | -6.00K | -2.00K | -2.00K |
| GrossAccountsReceivable | 4.92M | 3.71M | 9.33M | 1.78M |
| CashCashEquivalentsAndShortTermInvestments | 9.15M | 11.87M | 33.90M | 11.05M |
| OtherShortTermInvestments | 29.68M | 0.00 | 0.00 | |
| CashAndCashEquivalents | 9.15M | 11.87M | 33.90M | 11.05M |
| CashFinancial | 9.15M | 11.87M | 33.90M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -19.90M | -16.93M | -12.44M | -9.40M |
| IssuanceOfCapitalStock | 22.16M | 24.91M | 38.38M | 0.00 |
| CapitalExpenditure | -6.27M | -6.46M | -555.00K | -489.00K |
| EndCashPosition | 9.15M | 11.87M | 33.90M | 11.05M |
| BeginningCashPosition | 11.87M | 33.90M | 11.05M | 17.38M |
| EffectOfExchangeRateChanges | -84.00K | -160.00K | -549.00K | 88.00K |
| ChangesInCash | -2.63M | -21.87M | 23.40M | -6.42M |
| FinancingCashFlow | 19.39M | 22.92M | 35.76M | -1.05M |
| CashFlowFromContinuingFinancingActivities | 19.39M | 22.92M | 35.76M | -1.05M |
| NetOtherFinancingCharges | -3.98M | -1.99M | -2.63M | -1.05M |
| ProceedsFromStockOptionExercised | 1.21M | 0.00 | 10.00K | 3.00K |
| NetCommonStockIssuance | 22.16M | 24.91M | 38.38M | 0.00 |
| CommonStockIssuance | 22.16M | 24.91M | 38.38M | 0.00 |
| InvestingCashFlow | -8.40M | -34.32M | -481.00K | 3.55M |
| CashFromDiscontinuedInvestingActivities | 0.00 | |||
| CashFlowFromContinuingInvestingActivities | -8.40M | -34.32M | -481.00K | 3.55M |
| InterestReceivedCFI | 2.25M | 1.95M | 74.00K | 35.00K |
| NetInvestmentPurchaseAndSale | -4.38M | -29.80M | 0.00 | 4.00M |
| SaleOfInvestment | 0.00 | 4.00M | ||
| NetPPEPurchaseAndSale | -6.27M | -6.46M | -555.00K | -489.00K |
| PurchaseOfPPE | -6.27M | -6.46M | -555.00K | -489.00K |
| OperatingCashFlow | -13.62M | -10.46M | -11.88M | -8.92M |
| CashFromDiscontinuedOperatingActivities | 0.00 | 0.00 | ||
| CashFlowFromContinuingOperatingActivities | -13.62M | -10.46M | -11.88M | -8.92M |
| ChangeInWorkingCapital | 1.27M | 2.34M | -7.24M | 162.00K |
| ChangeInOtherWorkingCapital | 1.18M | |||
| ChangeInPayablesAndAccruedExpense | 923.00K | -1.52M | 695.00K | -261.00K |
| ChangeInPayable | 923.00K | -1.52M | 695.00K | -261.00K |
| ChangeInAccountPayable | 406.00K | -594.00K | 414.00K | 1.72M |
| ChangeInInventory | 187.00K | -906.00K | -721.00K | 257.00K |
| ChangeInReceivables | -1.02M | 4.76M | -7.22M | 166.00K |
| ChangesInAccountReceivables | -1.14M | 5.66M | -7.58M | 929.00K |
| OtherNonCashItems | -12.00K | -1.29M | 218.00K | 1.69M |
| StockBasedCompensation | 3.14M | 1.94M | 1.95M | 1.67M |
| DepreciationAmortizationDepletion | 1.48M | 1.30M | 1.27M | 1.24M |
| DepreciationAndAmortization | 1.48M | 1.30M | 1.27M | 1.24M |
| OperatingGainsLosses | 10.72M | -8.04M | 11.52M | -124.00K |
| PensionAndEmployeeBenefitExpense | -30.00K | 83.00K | 109.00K | 13.00K |
| GainLossOnInvestmentSecurities | 10.70M | -8.31M | 10.89M | |
| NetForeignCurrencyExchangeGainLoss | 47.00K | 189.00K | 525.00K | -137.00K |
| NetIncomeFromContinuingOperations | -30.22M | -6.72M | -19.60M | -13.55M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MDWD
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|